Schrödinger Future Growth
Future criteria checks 1/6
Schrödinger is forecast to grow earnings and revenue by 8.8% and 18.9% per annum respectively. EPS is expected to grow by 9% per annum. Return on equity is forecast to be -30.7% in 3 years.
Key information
8.8%
Earnings growth rate
9.0%
EPS growth rate
| Healthcare Services earnings growth | 30.7% |
| Revenue growth rate | 18.9% |
| Future return on equity | -30.7% |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher
Nov 13
Schrödinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty
Oct 17Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues
Sep 27Schrodinger: More Drug Discovery Validation
Aug 06Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation
Aug 05We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right
Jun 12Schrödinger: More Pharmaceutical Than Software
May 07Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar
May 02Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially
Mar 01Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024
Mar 01Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Feb 28The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%
Feb 01Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable
Dec 18Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Sep 28Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?
Jul 01Schrödinger: Q2 Earnings Supports Growth Narrative
Aug 26Schrödinger appoints Dr. Geoffrey Porges as finance chief
Aug 18Sizing Up Schrodinger
Jun 06Schrödinger: Holding The Keys To Discovery
Mar 26Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too
Mar 15Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be Critical
Jan 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 305 | -157 | -115 | N/A | 6 |
| 12/31/2025 | 265 | -169 | -162 | N/A | 11 |
| 12/31/2024 | 203 | -171 | -192 | N/A | 10 |
| 9/30/2024 | 193 | -178 | -172 | -164 | N/A |
| 6/30/2024 | 201 | -201 | -193 | -180 | N/A |
| 3/31/2024 | 188 | -143 | -159 | -145 | N/A |
| 12/31/2023 | 217 | 41 | -150 | -137 | N/A |
| 9/30/2023 | 199 | 44 | -137 | -124 | N/A |
| 6/30/2023 | 194 | 66 | -115 | -105 | N/A |
| 3/31/2023 | 197 | 14 | -121 | -111 | N/A |
| 12/31/2022 | 181 | -149 | -128 | -120 | N/A |
| 9/30/2022 | 170 | -153 | -122 | -114 | N/A |
| 6/30/2022 | 163 | -148 | -102 | -95 | N/A |
| 3/31/2022 | 154 | -135 | -108 | -99 | N/A |
| 12/31/2021 | 138 | -100 | -78 | -71 | N/A |
| 9/30/2021 | 125 | -81 | -14 | -7 | N/A |
| 6/30/2021 | 121 | -42 | -13 | -9 | N/A |
| 3/31/2021 | 114 | -11 | 9 | 12 | N/A |
| 12/31/2020 | 108 | -24 | 14 | 17 | N/A |
| 9/30/2020 | 101 | -20 | -40 | -38 | N/A |
| 6/30/2020 | 95 | -35 | -34 | -32 | N/A |
| 3/31/2020 | 91 | -33 | -29 | -27 | N/A |
| 12/31/2019 | 86 | -25 | -28 | -26 | N/A |
| 9/30/2019 | 77 | -24 | -26 | -24 | N/A |
| 6/30/2019 | 70 | -24 | -29 | -25 | N/A |
| 3/31/2019 | 69 | -29 | -29 | -25 | N/A |
| 12/31/2018 | 67 | -28 | -29 | -24 | N/A |
| 12/31/2017 | 56 | -17 | N/A | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SDGR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SDGR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SDGR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SDGR's revenue (18.9% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: SDGR's revenue (18.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SDGR is forecast to be unprofitable in 3 years.